False positive results of galactomannan ELISA assay in haemato-oncology patients: A single centre experience

Journal of Infection

Volumn 55, Issue 2, 2007, Pages 201-202

  Lim, Z Y ^a   Ho, A Y L ^a   Devereux, S ^a   Mufti, G J ^a   Pagliuca, A ^a   Wade, J ^a   Smith, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; GALACTOMANNAN; PIPERACILLIN PLUS TAZOBACTAM;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ASPERGILLOSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; LETTER; MAJOR CLINICAL STUDY; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ASPERGILLOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; MANNANS; NEOPLASMS;

EID: 34447096717     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.11.015     Document Type: Letter

References (11)

1. Ascioglu S., Rex J.H., De Pauw B., Bennett J.E., Bille J., Crokaert F., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7-14
2. Maertens J., Verhaegen J., Demuynck H., Brock P., Verhoef G., Vandenberghe P., et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Clin Microbiol 37 (1999) 3223-3228
3. Becker M.J., Lugtenburg E.J., Cornelissen J.J., Van Der Schee C., Hoogsteden H.C., and De Marie S. Galactomannan detection in computerized tomography-based bronchoalveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 121 (2003) 448-457
4. Herbrecht R., Letscher-Bru V., Oprea C., Lioure B., Waller J., Campos F., et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 20 (2002) 1898-1906
5. Rohrlich P., Sarfati J., Mariani P., Duval M., Carol A., Saint-Martin C., et al. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Paed Infect Dis J 15 (1996) 232-237
6. Marr K.A., Balajee S.A., McLaughlin L., Tabouret M., Bentsen C., and Walsh T.J. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190 3 (2004 Aug 1) 641-649
7. Swanink C.M., Meis J.F., Rijs A.J., Donnelly J.P., and Verweij P.E. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 35 (1997) 257-260
8. Sulahian A., Touratier S., and Ribaud P. False positive test for Aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349 (2003) 2366-2367
9. Ansorg R., van den Boom R., and Rath P.M. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 40 (1997) 353-357
10. Allan E.K., Jordanides N.E., McLintock L.A., Copland M., Devaney M., Stewart K., et al. Poor performance of galactomannan and mannan sandwich enzyme-linked immunosorbent assays in the diagnosis of invasive fungal infection. Br J Haematol 128 4 (2005) 578-579
11. Buchheidt D., Hummel M., Schleiermacher D., Spiess B., Schwerdtfeger R., Cornely O.A., et al. Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients. Br J Haematol 125 2 (2004 Apr) 196-202